Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock. The post Up 135% in a year ...

Children may have a higher risk of developing ADHD if their mothers used paracetamol – also known as acetaminophen – during ...

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

Outperformance during the fourth quarter primarily resulted from stock selection and an overweight in industrials. Read more ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Researchers are delving deeper into the role of leukocyte telomere length as it relates to stroke, dementia, and depression ...

Uncover the surprising health benefits of onions for managing diabetes, offering a natural path to better blood sugar control ...

Fintel reports that on February 7, 2025, Citigroup initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...